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a systematic analysis with implications for the Sustainable 
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Li Liu*, Yue Chu*, Shefali Oza, Dan Hogan, Jamie Perin, Diego G Bassani, Usha Ram, Shaza A Fadel, Arvind Pandey, Neeraj Dhingra, 
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Simon Cousens
Summary
Background India had the largest number of under-5 deaths of all countries in 2015, with substantial subnational 
disparities. We estimated national and subnational all-cause and cause-specific mortality among children younger 
than 5 years annually in 2000–15 in India to understand progress made and to consider implications for achieving the 
Sustainable Development Goal (SDG) child survival targets.
Methods We used a multicause model to estimate cause-specific mortality proportions in neonates and children aged 
1–59 months at the state level, with causes of death grouped into pneumonia, diarrhoea, meningitis, injury, measles, 
congenital abnormalities, preterm birth complications, intrapartum-related events, and other causes. AIDS and 
malaria were estimated separately. The model was based on verbal autopsy studies representing more than 
100 000 neonatal deaths globally and 16 962 deaths among children aged 1–59 months at the subnational level in 
India. By applying these proportions to all-cause deaths by state, we estimated cause-specific numbers of deaths and 
mortality rates at the state, regional, and national levels.
Findings In 2015, there were 25·121 million livebirths in India and 1·201 million under-5 deaths (under-5 mortality 
rate 47·81 per 1000 livebirths). 0·696 million (57·9%) of these deaths occurred in neonates. There were disparities in 
child mortality across states (from 9·7 deaths [Goa] to 73·1 deaths [Assam] per 1000 livebirths) and regions (from 
29·7 deaths [the south] to 63·8 deaths [the northeast] per 1000 livebirths). Overall, the leading causes of under-5 deaths 
were preterm birth complications (0·330 million [95% uncertainty range 0·279–0·367]; 27·5% of under-5 deaths), 
pneumonia (0·191 million [0·168–0·219]; 15·9%), and intrapartum-related events (0·139 million [0·116–0·165]; 
11·6%), with cause-of-death distributions varying across states and regions. In states with very high under-5 mortality, 
infectious-disease-related causes (pneumonia and diarrhoea) were among the three leading causes, whereas the 
three leading causes were all non-communicable in states with very low mortality. Most states had a slower decline in 
neonatal mortality than in mortality among children aged 1–59 months. Ten major states must accelerate progress to 
achieve the SDG under-5 mortality target, while 17 are not on track to meet the neonatal mortality target.
Interpretation Efforts to reduce vaccine-preventable deaths and to reduce geographical disparities should continue to 
maintain progress achieved in 2000–15. Enhanced policies and programmes are needed to accelerate mortality 
reduction in high-burden states and among neonates to achieve the SDG child survival targets in India by 2030.
Funding Bill & Melinda Gates Foundation.
Copyright © The Author(s). Published by Elsevier Ltd. This is an open access article under the CC BY 4.0 license.
Introduction
An estimated 1·201 million deaths occurred in children 
younger than 5 years in India in 2015—the largest 
number of such deaths among all countries. The number 
reduced from 2·516 million in 2000,1 yet despite this 
progress, India did not meet target 4 of the Millennium 
Development Goals (MDG 4) of a two-thirds reduction 
in under-5 mortality rate between 1990 and 2015.2 
During this period, there were substantial geographical 
disparities and socioeconomic inequalities in child 
survival within India.3–5
Information on national, regional, and state-level 
under-5 mortality rates and causes of deaths is of great 
value to guide health spending on child survival 
programmes. This is particularly true for India, with its 
decentralised health policy and decision making,6 
increasing national health budget,7 and growing domestic 
and international interests in vaccine introduction and 
scaling up.8–10 We have previously published reports on 
district-level all-cause child mortality for 2001 and 2012,11 
and on national and state-level causes of death in children 
for 2001–0312 and 2000–15,5 based on observed data from 
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India’s sample registration system. In this paper, as the 
Maternal and Child Epidemiology Estimation (MCEE) 
group, we provide estimates of all-cause and cause-
specific under-5 mortality, with a focus on cause-specific 
mortality, at the national, regional, and state levels 
annually for 2000–15. We also reflect on progress made 
with regard to child survival during the MDG period, and 
draw implications for achieving the child survival targets 
(≤25 under-5 deaths per 1000 livebirths and ≤12 neonatal 
deaths per 1000 livebirths by 2030) in the Sustainable 
Development Goals (SDG) era in India.13
Methods
Estimation of state-level livebirths, under-5 all-cause 
mortality rates, and numbers of deaths in 2000–15
We largely followed our previously published methods 
to estimate livebirths, under-5 all-cause mortality rates, 
and number of deaths per state (including union 
territories).11 We extracted state-level population totals 
from 1991, 2001, and 2011 national censuses,14 and 
interpolated for years between two adjacent censuses 
and extrapolated for 2012–15, assuming exponential 
annual growth rates. We estimated state-level crude 
birth rates using data from the sample registration 
system.15–17 For crude birth rates in 2015, we assumed the 
same state-level trends as those in 2000–14 and imputed 
for states with missing values. We calculated the number 
of livebirths in each state by multiplying crude birth 
rates by total population, and rescaled to match the 
national total number of livebirths estimated by the UN 
Population Division.18
We derived state-level neonatal mortality rates using 
similar methods and data sources to those used for crude 
birth rate, with missing values imputed on the basis of 
the relative relationship of infant mortality rate among 
states. State-level under-5 mortality rates were obtained 
with one of two approaches. For 20 large states, we used 
the under-5 mortality rate from the sample registration 
system,16 and calculated the rates for missing years before 
2008 using infant mortality rate and age-specific death 
rates at 1–4 years of age. For the remaining 15 states and 
union territories, we selected states with available data as 
references and, for those without data, imputed under-5 
mortality rates on the basis of the ratio of infant mortality 
to under-5 mortality in the reference state for each year. 
We calculated the number of neonatal and under-5 deaths 
in each state using state-level neonatal mortality rate or 
under-5 mortality rate and livebirth data, and rescaled to 
the national totals estimated by the UN Inter-Agency 
Group for Child Mortality Estimation.19 Additional details 
are available in the appendix (pp 4–6).
Estimation of national, regional, and state-level 
cause-specific mortality proportions in 2000–15
State-level cause-specific mortality proportions for neo- 
nates and children aged 1–59 months were estimated 
Research in context
Evidence before this study
We have been routinely reviewing and publishing studies on 
child mortality by cause estimates at global and national level 
since 2003. This study shared the same search strategies and 
screening criteria as our last publication for the 2000–15 period, 
with search terms covering child, mortality or death, and leading 
causes of deaths. We identified child cause-of-death studies 
published until Feb 12, 2015, in the following databases: 
PubMed, Embase, ISIS Web of Knowledge, Medline BIOSIS, 
Popline, WHOLIS, and IndMed. We have previously reported 
estimates of all-cause mortality at national and district levels for 
India for the years 2001 and 2012, as well as cause-specific child 
mortality estimates based on empirical data from the Million 
Deaths Study for major states and selected major causes for 
children younger than 5 years. The Global Burden of Disease 
Study has published mortality by cause among all age groups, 
including deaths among children younger than 5 years, in India. 
However, there are few data currently available for children 
younger than 5 years, especially at the subnational level, for the 
years 2000–15. Thus, this study aimed to fill this gap and provide 
more detailed modelled estimates by state, age, and cause.
Added value of this study
We present all-cause and cause-specific mortality estimates at 
state level annually for 2000–15 based on a comprehensive set 
of high-quality national and subnational verbal autopsy studies 
and a multicause model. We provide transparent time trends 
for neonates and children aged 1–59 months at national and 
subnational levels, reflect on achievements against Millennium 
Development Goal (MDG) 4, and highlight areas where greater 
efforts are required if states are to achieve the Sustainable 
Development Goal (SDG) 3 child survival targets by 2030.
Implications of all the available evidence
Information on child mortality by cause at the state, regional, 
and national levels shows that achievements with regard to 
child survival have been made in India in the MDG era, 
informing policy making and resource allocation in the SDG era. 
For example, efforts in integrated newborn care packages could 
further improve neonatal health outcomes. High and 
consistent commitment from local governments is crucial to 
reduce subnational disparities. Further work is required to 
improve the resolution of all-cause and cause-specific estimates 
to support decentralised decision making. Continued 
investment in high-quality and timely collection, 
dissemination, and use of child cause-of-death data at the 
subnational level in India is essential. Although some states are 
on track or have already achieved the SDG child mortality 
targets, ten of the 25 major states need to accelerate progress 
during 2015–30 to meet the under-5 mortality target, and 
17 need to accelerate progress to meet the neonatal mortality 
target by 2030.
See Online for appendix
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separately with multinomial logistic regression models 
using data from verbal autopsy studies. The analytical 
framework has been published elsewhere.1,20–24
The model input data were different for the two age 
groups. For neonates, input data from all countries with 
high mortality where verbal autopsy studies were available 
were used.1 The rationale for using verbal autopsy studies 
from all countries with high mortality is provided in the 
appendix (p 7). 124 verbal autopsy datapoints were 
included, covering more than 100 000 neonatal deaths 
across 37 countries. After the model had been para- 
meterised, state covariates were used to predict state-level 
neonatal cause-specific mortality proportions.
For children who died at between 1 month and 
59 months of age, we developed a subnational verbal-
autopsy-based multicause model, using only subnational 
verbal autopsy studies from India to best account for the 
cause-of-death profile in this unique setting (appendix 
pp 7–8). Verbal autopsy studies were identified through a 
comprehensive literature review.1,24 Unpublished high-
quality verbal autopsy studies were identified by contacting 
known investigators. 50 datapoints from 16 subnational 
verbal autopsy studies across 23 states were used, 
representing 16 962 deaths. We also extracted study 
covariate values when available in the verbal autopsy 
studies, or else used estimates of the highest possible 
geographical time resolution from other sources.4,25,26
We excluded deaths due to AIDS and malaria in the 
multinomial model because they were difficult to 
estimate stably because of the low disease burden. 
Instead, AIDS and malaria were estimated separately. 
AIDS deaths per state were estimated by the Indian 
Council of Medical Research using Spectrum, an 
analytical software that has been routinely used by 
UNAIDS. Malaria deaths per state were estimated by the 
WHO Malaria Programme on the basis of reported 
malaria cases and case fatality rates.27 Details of AIDS 
and malaria death estimation are provided in the 
appendix (pp 8–9). We applied the state share of deaths 
due to AIDS and malaria to national estimates produced 
by UNAIDS and WHO, respectively, to derive state-level 
estimates.
We grouped the remaining causes of death into the 
following categories, based on International Classification 
of Diseases 10th revision:24 pneumonia, diarrhoea, 
meningitis, injury, measles, congenital abnormalities, 
causes originating in the perinatal period (ie, preterm 
birth complications and intrapartum-related events), and 
other. Ordinary least-squares regression was used to 
identify possible covariates for the log-ratio of the 
proportion of each of the seven causes relative to 
pneumonia (reference). The final model was selected on 
the basis of results from cross-validation.1 We then fitted 
the multinomial logistic regression model with robust 
SEs to obtain parameter estimates, with study datapoints 
weighted proportionally to the inverse of the square root 
of the total number of deaths.
After the verbal-autopsy-based multicause model had 
been parameterised, we used state covariates to predict 
state-level cause-specific mortality proportions. Details of 
how the state prediction covariate database was prepared 
and the final covariates retained are provided in the 
appendix (p 11). We then applied the age-specific and state-
specific cause-specific mortality proportions to numbers 
of deaths (excluding those due to AIDS and malaria) to 
Total 
livebirths
All under-5 deaths Deaths in infants 
aged 0–28 days
Deaths in children 
aged 1–59 months
Total Per 1000 
livebirths
Total Per 1000 
livebirths
Total Per 1000 
livebirths
India 25 121 029 1 200 998 47·81 695 852 27·70 505 146 20·11
Region
Central 9 512 025 575 973 60·55 328 335 34·52 247 638 26·03
East 5 823 480 286 833 49·25 166 061 28·52 120 773 20·74
North 1 733 503 60 924 35·15 36 932 21·30 23 992 13·84
Northeast 932 280 59 446 63·76 22 547 24·18 36 899 39·58
South 4 046 896 120 126 29·68 79 772 19·71 40 354 9·97
West 3 072 844 97 696 31·79 62 206 20·24 35 490 11·55
State
Andhra Pradesh 
and Telangana
1 409 102 55 920 39·68 35 392 25·12 20 528 14·57
Assam 685 611 50 129 73·12 18 694 27·27 31 435 45·85
Bihar 2 832 353 148 484 52·42 83 026 29·31 65 458 23·11
Chhattisgarh 620 865 32 267 51·97 19 339 31·15 12 928 20·82
Delhi 280 798 6869 24·46 4583 16·32 2286 8·14
Goa 17 485 170 9·72 115 6·58 55 3·15
Gujarat 1 256 413 54 095 43·06 32 738 26·06 21 357 17·00
Haryana 526 637 22 645 43·00 13 482 25·60 9163 17·40
Himachal 
Pradesh
103 513 4133 39·93 2536 24·50 1598 15·44
Jammu and 
Kashmir
217 654 8503 39·07 6412 29·46 2091 9·61
Jharkhand 809 086 37 592 46·46 22 431 27·72 15 160 18·74
Karnataka 1 047 947 34 038 32·48 24 218 23·11 9820 9·37
Kerala 466 438 5832 12·50 2930 6·28 2902 6·22
Madhya 
Pradesh
1 859 145 124 693 67·07 66 916 35·99 57 776 31·08
Maharashtra 1 784 820 42 954 24·07 29 063 16·28 13 891 7·78
Meghalaya 72 388 4465 61·68 1665 23·00 2800 38·68
Northeastern 
states*
174 281 4852 27·84 2188 12·55 2664 15·29
Odisha 785 330 50 363 64·13 30 000 38·20 20 363 25·93
Other states† 53 096 1275 24·01 799 15·05 476 8·96
Punjab 412 754 11 483 27·82 5712 13·84 5771 13·98
Rajasthan 1 708 901 93 513 54·72 54 430 31·85 39 082 22·87
Tamil Nadu 1 098 325 23 849 21·71 16 905 15·39 6944 6·32
Uttar Pradesh 5 323 115 325 500 61·15 187 649 35·25 137 851 25·90
Uttarakhand 178 264 6980 39·16 4024 22·57 2956 16·58
West Bengal 1 396 712 50 395 36·08 30 604 21·91 19 792 14·17
*Arunachal Pradesh, Manipur, Mizoram, Nagaland, Sikkim, and Tripura. †Andaman and Nicobar Islands, Chandigarh, 
Dadra and Nagar Haveli, Daman and Diu, Lakshadweep, and Puducherry.
Table 1: Estimated numbers of livebirths and infant and child deaths at the national, regional, and state 
levels in India in 2015
For more on Spectrum see 
https://www.avenirhealth.org/
software-spectrum.php
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derive age-specific and cause-specific numbers of deaths. 
Among children who died between the ages of 1 month 
and 59 months, to account for the effects of the recent 
scaling up (ie, up to 2015) of the Haemophilus influenzae 
type b (Hib) vaccine on deaths due to pneumonia and 
meningitis, we included a post-hoc adjustment, details of 
which have been published previously1,23 (for a summary 
see appendix pp 11–12).
We applied the state-level cause-specific mortality 
proportions by age to state-specific and age-specific all-
cause deaths to derive age-specific and cause-specific 
numbers of deaths annually from 2000 to 2015 for each of 
the 35 states. An overview of the estimation process is 
shown in the appendix (p 13). Uncertainty ranges were 
calculated with use of bootstrap resampling of the input 
data with replacement.1 The 2·5th and 97·5th percentiles 
were taken as the lower and upper limits of the uncertainty.
Estimates reporting, comparison, and transparency
We report deaths by cause for each of the 23 major states, 
with the 12 smaller states grouped into northeastern 
states (Arunachal Pradesh, Manipur, Mizoram, Nagaland, 
Sikkim, and Tripura) and other states (Andaman and 
Nicobar Islands, Chandigarh, Dadra and Nagar Haveli, 
Daman and Diu, Lakshadweep, and Puducherry) on the 
basis of geographical location (appendix p 14). Small 
states were defined as those with fewer than 1500 deaths 
in 2015, except for Goa. We report Andhra Pradesh and 
Telangana together in 2014 and 2015 because Telangana 
was separated from Andhra Pradesh in June, 2014. The 
states of Bihar, Chhattisgarh, Madhya Pradesh, Odisha, 
Rajasthan, Uttar Pradesh, Jharkhand, and Uttaranchal, 
which are the least developed and lag behind the rest of 
India in terms of demographic transition, constitute the 
Empowered Action Group (EAG).28 Together with Assam, 
they are referred to as the EAGA states.
We report estimates nationally and by state, region 
(north, northeast, east, central, west, and south), and 
EAGA status (appendix p 14). We also classified states 
into five strata of under-5 mortality rate: very high 
mortality (>65 deaths per 1000 livebirths), high mortality 
(>55 to 65 deaths per 1000 livebirths), medium 
mortality (>45 to 55 deaths per 1000 livebirths), low 
mortality (>25 to 45 deaths per 1000 livebirths), and very 
low mortality (≤25 deaths per 1000 livebirths; see 
appendix p 14 for groupings). Annual rates of reduction24 
were used to describe the pace of decline in mortality, 
and were benchmarked against 4·4%—the annual rate 
of reduction required to reach MDG 4 (appendix p 12).
We compared our estimates with other estimates 
for the same period based on the 2000–15 Million 
Death Study (MDS)5 and the 1980–2016 Global Burden 
of Disease (GBD) study.29 Constrained by estimate 
availability and accessibility, we were only able to 
compare cause-specific mortality proportions for 2015 at 
the national level across the three sources, and compared 
trends in cause-specific mortality rates between MCEE 
and MDS at the national and state levels.
Our study conformed to the Guidelines for Accurate 
and Transparent Health Estimates Reporting (GATHER) 
statement (appendix p 15).30 Analyses were done with 
Stata software (version 15.1).
Role of the funding source
The funder of the study had no role in study design, data 
collection, data analysis, data interpretation, or writing of 
the report. All authors had full access to all the data in 
the study, and the corresponding author had final 
responsibility for the decision to submit for publication.
Results
In 2015, an estimated 25·121 million children were born 
in India, and 1·201 million children died before the age 
of 5 years, equating to an under-5 mortality rate of around 
47·81 per 1000 livebirths (table 1). 0·696 million (57·9%) 
of these under-5 deaths occurred in the neonatal period 
(neonatal mortality rate 27·70 per 1000 livebirths). Large 
disparities existed across regions, with the highest 
RJ
MP
MH
UP
GJ
KA
AP*
OD
TN
JK
CG
TL*
BR
JH
AR
AS
WB
HP
UK
PB
HR
MZ
MN
NG
KL
MG
TP
SK
GO
DL
DN
PD
PD
CH
PD
PD
DD
Region Under-5 mortality rate
(per 1000 livebirths)
LK
AN
Central
East
North
Northeast
South
West
≤25
>25–45
>45–55
>55–65
>65
Figure 1: Under-5 mortality by state in 2015
AN=Andaman and Nicobar. AP=Andhra Pradesh. AR=Arunachal Pradesh. AS=Assam. BR=Bihar. CG=Chhattisgarh. 
CH=Chandigarh. DD=Daman and Diu. DL=National Capital Territory of Delhi. DN=Dadra and Nagar Haveli. GO=Goa. 
GJ=Gujarat. HR=Haryana. HP=Himachal Pradesh. JK=Jammu and Kashmir. JH=Jharkhand. KA=Karnataka. KL=Kerala. 
LK=Lakshadweep. MG=Meghalaya. MH=Maharashtra. MN=Manipur. MP=Madhya Pradesh. MZ=Mizoram. 
NG=Nagaland. OD=Odisha. PB=Punjab. PD=Puducherry. RJ=Rajasthan. SK=Sikkim. TL=Telangana. TN=Tamil Nadu. 
TP=Tripura. UK=Uttarakhand. UP=Uttar Pradesh. WB=West Bengal. *TL is reported together with AP.
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Preterm birth 
complications
Intrapartum-
related events
Sepsis or 
meningitis
Congenital Pneumonia Tetanus Injury Diarrhoea Other disorders
India 306 462 
(256 814–342 719), 
25·5%
132 900  
(109 692–158 231),  
11·1%
95 046 
(62 027–130 094),  
7·9%
71 802 
(56 681–92 640),  
6·0%
36 151  
(21 709–58 758),  
3·0%
6788  
(3314–16 655),  
0·6%
5472 
(2814–8014),  
0·5%
5331  
(2898–28 312), 
0·4%
35 900  
(18 480–52 560),  
3·0%
Region
Central 157 218  
(128 320–177 767), 
27·3%
58 855 
(46 924–71 605), 
10·2%
43 783 
(27 020–62 189),  
7·6%
25 671 
(19 970–36 038),  
4·5%
16 906  
(10 383–27 229), 
 2·9%
4158  
(2036–9964),  
0·7%
2475  
(1148–3809),  
0·4%
3037  
(1605–18 758),  
0·5%
16 232 
(7540–24 971), 
2·8%
East 70 525  
(58 380–80 167), 
24·6%
32 730 
(26 737–39 318),  
11·4%
24 695 
(15 993–33 819),  
8·6%
16 284  
(12 742–21 227),  
5·7%
8679  
(5297–13 943),  
3·0%
1453  
(684–3753),  
0·5%
1374  
(688–2094),  
0·5%
1303  
(696–6422),  
0·5%
9018  
(4520–13 733), 
3·1%
North 14 077  
(12 268–15 611), 
23·1%
7867  
(6730–9115),  
12·9%
4837  
(3306–6421),  
7·9%
5480  
(4073–6997),  
9·0%
1989  
(1129–3370), 
3·3%
240  
(113–627),  
0·4%
299  
(180–399),  
0·5%
184  
(97–778),  
0·3%
1959  
(1182–2614), 
3·2%
Northeast 10 171 
(8739–11 342), 
17·1%
4628 
(3877–5360),  
7·8%
2891 
(1845–4011),  
4·9%
1828  
(1484–2529), 
3·1%
1245 
(765–2002), 
2·1%
183  
(86–478),  
0·3%
186  
(99–274),  
0·3%
193  
(104–788),  
0·3%
1222  
(650–1797), 
2·1%
South 28 114 
(22 523–33 522), 
23·4%
17 047 
(13 729–20 786),  
14·2%
11 346 
(7678–15 770),  
9·4%
13 612  
(9470–17 631),  
11·3%
4042 
(2045–7472),  
3·4%
325  
(136–910),  
0·3%
667  
(390–916),  
0·6%
242  
(80–1294),  
0·2%
4377  
(2569–6014), 
3·6%
West 26 357 
(22 713–29 698), 
27·0%
11 774 
(9959–14 224), 
12·1%
7494  
(4935–10 227),  
7·7%
8927  
(6206–11 589),  
9·1%
3290  
(1984–5641),  
3·4%
430  
(206–1167),  
0·4%
471  
(248–687),  
0·5%
372  
(233–960),  
0·4%
3091  
(1633–4507), 
3·2%
State
Andhra Pradesh 
and Telangana
12 390 
(9472–15 241), 
22·2%
7822
(6105–9591), 
14·0%
5520  
(3706–7670),  
9·9%
5283  
(3942–6871),  
9·4%
1789  
(895–3288),  
3·2%
157  
(64–436),  
0·3%
306 
(175–426),  
0·5%
119  
(27–836),  
0·2%
2007  
(1148–2796),  
3·6%
Assam 8740 
(7353–9847),  
17·4%
3668 
(3014–4355),  
7·3%
2470  
(1541–3448),  
4·9%
1290  
(1004–1953),  
2·6%
1024  
(633–1648),  
2·0%
149  
(67–402),  
0·3%
156  
(71–242),  
0·3%
176  
(94–723),  
0·4%
1021  
(466–1588), 
2·0%
Bihar 36 289 
(28 632–42 417), 
24·4%
16 280  
(12 797–20 048),  
11·0%
12 291  
(7591–16 952), 
8·3%
7381  
(5637–10 029),  
5·0%
4321  
(2692–6859),  
2·9%
786  
(349–2157),  
0·5%
656  
(321–1034),  
0·4%
718  
(377–3210),  
0·5%
4304  
(2111–6786),  
2·9%
Chhattisgarh 6951 
(5670–7915),  
21·5%
4527 
(3756–5325), 
14·0%
3164 
(2126–4125),  
9·8%
1980  
(1561–2636),  
6·1%
1071  
(666–1700),  
3·3%
204  
(97–525),  
0·6%
172  
(98–244),  
0·5%
143  
(59–1015),  
0·4%
1128  
(644–1602),  
3·5%
Delhi 1832  
(1523–2207), 
26·7%
817  
(670–999),  
11·9%
667  
(446–989),  
9·7%
672  
(396–913), 
9·8%
240 
(146–414),  
3·5%
<30,  
0·2%
42  
(17–62),  
0·6%
<30,  
0·4%
274  
(111–405),  
4·0%
Goa 40  
(30–50), 23·5%
<30,  
13·5%
<30,  
6·5%
<30,  
17·0%
<30,  
3·5%
<30, 
0·0%
<30,  
0·6%
<30,  
0·0%
<30,  
2·9%
Gujarat 15 203 
(12 330–17 241),  
28·1%
5976  
(4866–7418), 
11·0%
4094  
(2492–5871),  
7·6%
3189  
(2386–4327), 
5·9%
1787 
(1181–2970),  
3·3%
332  
(160–912),  
0·6%
248  
(100–410),  
0·5%
282  
(168–762),  
0·5%
1627  
(657–2692), 
3·0%
Haryana 5250 
(4494–5979),  
23·2%
2944  
(2443–3398), 
13·0%
1646 
(1087–2206),  
7·3%
1966  
(1522–2545),  
8·7%
731  
(383–1280),  
3·2%
101  
(45–272),  
0·4%
103  
(63–137),  
0·5%
62  
(24–333),  
0·3%
677  
(413–895),  
3·0%
Himachal 
Pradesh
1031  
(903–1151),  
24·9%
523  
(452–605), 
12·7%
283  
(182–397),  
6·8%
382  
(291–492),  
9·2%
137  
(72–250),  
3·3%
<30 
(7–38),  
0·4%
<30  
(12–28),  
0·5%
<30  
(6–48),  
0·3%
133  
(77–182),  
3·2%
Jammu and 
Kashmir
2094  
(1685–2414),  
24·6%
1554  
(1293–1848), 
18·3%
1015  
(708–1304),  
11·9%
876  
(659–1133),  
10·3%
353  
(212–588),  
4·2%
66  
(31–168),  
0·8%
55  
(33–78),  
0·6%
35  
(12–266),  
0·4%
363  
(216–514),  
4·3%
Jharkhand 10 246  
(8097–11 630),  
27·3%
4160  
(3321–5167),  
11·1%
3001  
(1767–4503),  
8·0%
2013  
(1512–2767), 
5·4%
1215  
(797–1996),  
3·2%
206  
(95–566),  
0·5%
183  
(79–304),  
0·5%
203  
(116–647),  
0·5%
1202  
(522–1996), 
3·2%
Karnataka 8790  
(7049–10 329),  
25·8%
5160  
(4178–6347),  
15·2%
3291  
(2220–4496),  
9·7%
4086  
(2899–5306), 
12·0%
1242  
(622–2298),  
3·6%
117  
(51–316), 
0·3%
193  
(113–276),  
0·6%
73  
(25–358),  
0·2%
1265  
(742–1811), 
3·7%
(Table 2 continues on next page
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under-5 mortality rates in the northeast region 
(63·8 deaths per 1000 livebirths) and central region 
(60·6 deaths per 1000 livebirths), both more than twice 
that of the south region (29·7 deaths per 1000 livebirths). 
After the south region, the lowest rates were observed in 
the west (31·8 deaths per 1000 livebirths) and north 
(35·2 deaths per 1000 livebirths) regions, increasing to 
49·3 deaths per 1000 livebirths in the east region. 
Under-5 mortality rate in EAGA states (58·7 deaths per 
1000 livebirths) was more than 1·8 times that of the 
non-EAGA states (32·1 deaths per 1000 livebirths).
States with the highest burden (numbers) of under-5 
deaths were mostly those clustered in the central and east 
regions, with half of all under-5 deaths occurring in three 
states: Uttar Pradesh, Bihar, and Madhya Pradesh (table 1). 
A similar clustering pattern was observed for neonatal 
death burden. The highest under-5 mortality rates were in 
Assam (73·1 per 1000 livebirths), Madhya Pradesh (67·1 
per 1000 livebirths), and Odisha (64·1 per 1000 livebirths), 
whereas the lowest rates were in Goa (9·7 per 
1000 livebirths), Kerala (12·5 per 1000 livebirths) and Tamil 
Nadu (21·7 per 1000 livebirths; figure 1). The proportion of 
neonatal deaths (out of all under-5 deaths) ranged from 
37·3% (in Meghalaya) to 75·4% (in Jammu and Kashmir).
Nationally, the leading causes of under-5 deaths in 
2015 were preterm birth complications (0·330 million 
[95% uncertainty range 0·279–0·367]; 27·5% of under-5 
deaths), pneumonia (0·191 million [0·168–0·219]; 
15·9%), and intrapartum-related events (0·139 million 
[0·116–0·165]; 11·6%). Among neonates, the leading 
Preterm birth 
complications
Intrapartum-
related events
Sepsis or 
meningitis
Congenital Pneumonia Tetanus Injury Diarrhoea Other disorders
(Continued form previous page)
Kerala 936  
(757–1179),  
16·0%
587  
(472–745),  
10·1%
354  
(228–540),  
6·1%
703  
(383–945),  
12·1%
145  
(71–293),  
2·5%
<30,  
0·1%
<30,  
0·4%
<30, 
0·1%
170  
(94–233),  
2·9%
Madhya 
Pradesh
35 503  
(27 928–40 886), 
28·5%
10 400  
(7762–13 161),  
8·3%
7694  
(4358–11 463), 
6·2%
5317  
(3868–8210), 
4·3%
3278  
(1769–5748), 
2·6%
762  
(363–1990), 
0·6%
4470  
(187–746),  
0·4%
582  
(291–3671),  
0·5%
2932  
(1226–4894),  
2·4%
Maharashtra 11 007  
(9411–12 685), 
25·6%
5710  
(4778–6936),  
13·3%
3349  
(2225–4646),  
7·8%
5671  
(3570–7443),  
13·2%
1480  
(758–2835),  
3·4%
95  
(39–282),  
0·2%
220  
(131–304),  
0·5%
88  
(46–192),  
0·2%
1443  
(862–1991),  
3·4%
Meghalaya 654  
(550–750),  
14·6%
430  
(358–486),  
9·6%
179  
(113–249),  
4·0%
173  
(141–233),  
3·9%
98  
(57–156),  
2·2%
<30,  
0·4%
<30,  
0·3%
<30,  
0·2%
89  
(56–116),  
2·0%
Northeastern 
states*
777  
(660–892),  
16·0%
529  
(442–627),  
10·9%
242  
(158–330),  
5·0%
365  
(255–475), 
7·5%
123  
(72–202),  
2·5%
<30,  
0·3%
<30, 
0·4%
<30,  
0·2%
112  
(74–150),  
2·3%
Odisha 13 368  
(10 920–15 194), 
26·5%
5653  
(4561–6663), 
11·2%
4444  
(2828–6134),  
8·8%
2460  
(1913–3513), 
4·9%
1564  
(911–2549),  
3·1%
346  
(171–810), 
0·7%
250  
(110–388),  
0·5%
271  
(119–2132),  
0·5%
1644  
(722–2547),  
3·3%
Other states† 305  
(261–349),  
23·9%
162  
(137–197), 
12·7%
93  
(61–124),  
7·3%
145  
(93–191),  
11·4%
42 
(25–75),  
3·3%
<30,  
0·3%
<30,  
0·5%
<30,  
0·3%
39  
(23–55),  
3·1%
Punjab 2118  
(1794–2451),  
18·4%
1188  
(990–1430),  
10·3%
666  
(446–905),  
5·8%
1083  
(726–1419),  
9·4%
299  
(152–555),  
2·6%
<30,  
0·2%
43  
(26–58),  
0·4%
<30,  
0·1%
282  
(172–383),  
2·5%
Rajasthan 30 402 
(22 711–34 993),  
32·5%
7244  
(5129–10 185), 
7·7%
6784  
(3782–10 781), 
7·3%
4089  
(2917–6081),  
4·4%
2490  
(1359–4529),  
2·7%
490  
(236–1238),  
0·5%
342  
(126–641),  
0·4%
347  
(146–1712),  
0·4%
2243  
(831–4207),  
2·4%
Tamil Nadu 5873  
(5003–7020), 
24·6%
3414  
(2829–4113), 
14·3%
2148  
(1446–3096),  
9·0%
3470  
(2062–4592),  
14·6%
850  
(441–1572),  
3·6%
45  
(17–139),  
0·2%
140  
(83–185),  
0·6%
44  
(22–96),  
0·2%
921  
(547–1212),  
3·9%
Uttar Pradesh 84 362  
(68 772–95 759), 
25·9%
36 685  
(29 468–43 882), 
11·3%
26 140  
(16 241–36 674),  
8·0%
14 286  
(11 010–20 026),  
4·4%
10 066  
(6461–15 811),  
3·1%
2702  
(1329–6427),  
0·8%
1514  
(722–2220),  
0·5%
1965  
(1025–12 211),  
0·6%
9928  
(4736–14 553),  
3·1%
Uttarakhand 1677  
(1429–1919), 
24·0%
805  
(679–948), 
11·5%
541  
(354–749),  
7·8%
465  
(343–606),  
6·7%
221  
(142–355),  
3·2%
<30,  
0·4%
34  
(16–49),  
0·5%
33  
(20–77),  
0·5%
222  
(108–320),  
3·2%
West Bengal 10 622 
(8927–12 207), 
21·1%
6637  
(5574–7875), 
13·2%
4959  
(3375–6854),  
9·8%
4430  
(3219–5670),  
8·8%
1578  
(868–2723),  
3·1%
114 
(46–341),  
0·2%
285  
(155–395),  
0·6%
111  
(46–424),  
0·2%
1869  
(1018–2590),  
3·7%
Data are n (95% uncertainty interval), % of total under-5 deaths. *Arunachal Pradesh, Manipur, Mizoram, Nagaland, Sikkim, and Tripura. †Andaman and Nicobar Islands, Chandigarh, Dadra and Nagar Haveli, Daman and Diu, 
Lakshadweep, and Puducherry.
Table 2: Estimated numbers of cause-specific deaths in infants aged 0–28 days at the national, regional, and state levels in India in 2015
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causes were preterm birth complications (0·306 million 
[0·257–0·343]; 44·0% of all neonatal deaths), intrapartum-
related events (0·133 million [0·110–0·158]; 19·1%), 
and neonatal sepsis or meningitis (0·095 million 
[0·062–0·130]; 13·7%; table 2, figure 2). Among children 
who died between 1 month and 59 months of age, 
pneumonia (0·155 million [0·138–0·172]; 30·6%), 
diarrhoea (0·107 million [0·096–0·117]; 21·3%), and 
injuries (0·037 million [0·030–0·043]; 7·3%) were the 
leading causes (table 3, figure 2).
Cause-of-death distributions also varied across regions 
(tables 2, 3; appendix p 16). The two leading causes of 
death were preterm birth complications and pneumonia 
in all regions except in the south region (the region with 
the lowest under-5 mortality rate), where preterm birth 
complications and congenital abnormalities were the 
most prominent. Diarrhoea was the third leading cause in 
the northeast region, which had the highest under-5 
mortality rate.
EAGA states (vs non-EAGA states) had a lower proportion 
of neonatal deaths (56·0% vs 63·2%), but higher pro-
portions of preterm birth complications (28·1% vs 25·7%) 
and diarrhoea (10·6% vs 6·3%) as causes of death 
(appendix p 17). The distribution of the remaining causes 
of deaths was similar between the two groups.
Cause-of-death distribution also varied by stratum of 
under-5 mortality rate (figure 3). In states with a very low 
under-5 mortality rate (where the SDG under-5 mortality 
rate target of ≤25 deaths per 1000 livebirths has already 
been achieved),13 the three leading causes of death were 
all non-communicable: preterm birth complications 
(26·4% of under-5 deaths), congenital abnormalities 
(17·1%), and intrapartum-related events (13·6%). By 
contrast, infectious diseases were more important in 
states with a very high under-5 mortality rate (>65 deaths 
per 1000 livebirths), with the three leading causes 
being preterm birth complications (27·4%), pneumonia 
(18·7%), and diarrhoea (11·2%).
Uttar Pradesh and Bihar had the largest numbers of 
under-5 deaths, contributing 39·5% of the national total 
(table 1). The cause-of-death distributions in these 
two states were similar. Among neonates, preterm birth 
complications (25·9% of under-5 deaths in Uttar Pradesh, 
and 24·4% in Bihar) and intrapartum-related events 
(11·3% and 11·0%) were the most common causes of 
death, and pneumonia (13·4% and 14·0%) and diarrhoea 
(10·9% and 10·8%) were the leading causes among 
children aged 1–59 months in these two states. Neonatal 
deaths accounted for higher proportions of under-5 deaths 
in states with low mortality rates, such as Andhra Pradesh 
(63·3%) and Delhi (66·7%), than in Uttar Pradesh (57·6%) 
and Bihar (55·9%). Congenital abnormalities were among 
the top three leading causes of under-5 mortality in Andhra 
Pradesh and Delhi (appendix p 18).
Between 2000 and 2015, the number of livebirths 
decreased from 27·797 to 25·121 million in India,19 
while the number of under-5 deaths decreased from 
2·516 to 1·201 million, representing 32·7% of the global 
reduction in under-5 deaths.1 The under-5 mortality rate 
in India decreased from 90·5 to 47·8 per 1000 livebirths 
during this period (a 47·2% reduction). The proportion 
of neonatal deaths (among under-5 deaths) increased 
from 49·8% to 57·9% (appendix p 19).
Child survival disparities, measured by the ratio of the 
highest regional under-5 mortality rate (in the northeast 
region) to the lowest (south region), increased from 
1·4 to 2·1 in 2000–15. This increase appeared to accelerate 
after 2005 (appendix p 20). The northeast region had the 
slowest decline in under-5 mortality rate, with an annual 
rate of reduction of 2·2% compared with at least 4·0% in 
other regions in this period.
Reductions in under-5 mortality rate also varied greatly 
across states, from 62·6% in Tamil Nadu to 26·2% in 
Assam. Of the five states with the highest under-5 mortality 
rate in 2000, four (Madhya Pradesh, Odisha, Uttar Pradesh, 
and Rajasthan) reduced their under-5 mortality rate by 
nearly half (46·6–49·3%). The exception was Assam, 
which had the smallest reduction in under-5 mortality rate 
during 2000–15, and had the highest under-5 mortality rate 
in 2015. When the reduction was annualised, ten of the 
25 major states had annual rate of reduction in under-5 
mortality rate greater than 4·4%. Most states (80%) had 
much slower declines in neonatal mortality rate than those 
among children aged 1–59 months. Uttar Pradesh, for 
example, had one of the highest annual rates of reduction 
among children aged 1–59 months (6·1%), but one of the 
lowest annual rates of reduction in neonatal mortality rate 
(2·9%; appendix pp 21–22).
Cause-specific mortality proportions changed gradually 
at the national level during 2000–15 (appendix pp 23–24). 
The three leading causes of death among neonates 
(preterm birth complications, intrapartum-related events, 
Figure 2: Distribution of causes of under-5 deaths in 2015
Causes are separated by age group (<1 month and 1–59 months).
Pneumonia 3·0%
Pneumonia 12·9% Preterm birth complications 25·5%
Preterm birth complications 2·0% Intrapartum-related
events 11·1%
Intrapartum-related events 0·5%
Sepsis or meningitis 7·9%
Meningitis 2·2%
AIDS 0·3%
Malaria 0·6%
Injury 3·1%
Measles 1·9%
Diarrhoea 8·9% Other 3·4%
Other 7·4%
Congenital disorders 6·0%
Tetanus 0·6 %
Diarrhoea 0·4 %
Congenital disorders 2·3%
Postneonatal death 42·1% Neonatal death 57·9%
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and sepsis or meningitis) were the same in 2000 and in 
2015. Preterm birth complications were consistently the 
leading cause of death among neonates, with a cause-
specific mortality rate that decreased slowly over time 
(annual rate of reduction 1·1%). The rate of mortality due 
to intrapartum-related events fell by more than 50% 
between 2000 and 2015, with an annual rate of reduction 
of 5·2%. The annual rate of reduction in neonatal cause-
specific mortality was highest for tetanus (14·8%), while 
neonatal congenital abnormalities increased slightly 
(annual rate of reduction –0·1%; appendix p 25).
Among children aged 1–59 months, the three leading 
causes of death in 2000 were all related to infectious 
diseases: pneumonia, diarrhoea (including all cases), and 
measles. During 2000–15, the measles-specific mortality 
rate declined rapidly and, by 2015, injuries had overtaken 
as the third leading cause of death in this age group 
(appendix p 24). Annual rates of reduction in this age 
group ranged from 2·0% (for congenital abnormalities) 
to 7·1% (for measles; appendix p 25).
Disparities in annual rates of reduction in 2000–15 
were observed across causes and across states (appen-
dix pp 26–27). Generally, annual rate of reductions were 
higher for infectious causes than for non-communicable 
causes across states.
Although a few states have already achieved and some 
others are on track to achieve the SDG child survival 
targets, the remaining states, and India as a whole, will 
need to accelerate progress substantially. To achieve the 
SDG under-5 mortality rate target by 2030, ten of the 
25 major states need to accelerate progress in terms of 
their annual rate of reduction during 2015–30 (figure 4), 
including the four states (Uttar Pradesh, Bihar, Madhya 
Pradesh, and Rajasthan) with the largest numbers of 
under-5 deaths. To achieve the neonatal mortality rate 
targets, 17 of the 25 major states need to accelerate 
progress (figure 4).
Discussion
In 2015, India had the largest number of under-5 deaths 
globally, and almost 60% of these deaths occurred in the 
neonatal period. Compared with estimates from the 
National Family Health Survey 4, our estimated under-5 
mortality rate and neonatal mortality rate were similar in 
the 2010–15 period, but showed a faster decline since 2000, 
both nationally and in major states.3 The leading causes of 
death were preterm birth complications, pneumonia, and 
intrapartum-related events. Neonatal sepsis or meningitis, 
diarrhoea, and injuries were also important causes. 
Under-5 mortality rate almost halved in India between 
2000 and 2015, largely due to fast declines in causes that 
could be potentially addressed by vaccines. Although 
mortality due to intrapartum-related events declined 
substantially in 2000–15, mortality due to preterm birth 
complications showed little change, suggesting 
improvements in labour and delivery practices but not in 
care of neonates born preterm. For example, programmes 
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to increase institutional births, ambulance support for 
referral, and caesarean section in areas where these 
facilities were low3 might have contributed to the decline in 
intrapartum-related events. However, the establishment of 
several hundred district neonatal intensive care units31 
does not appear to have had a noticeable effect on mortality 
due to preterm birth complications.
Geographical and socioeconomic disparities in child 
survival exist throughout India. Regional disparities 
worsened during 2000–15, especially after 2005. 
Pneumonia and diarrhoea were among the top 
three leading causes in the northeast region, which had 
the highest under-5 mortality rate. Preterm birth 
complications were particularly important in the EAGA 
states. Disparities were also present across age groups 
and causes. In the majority of the states, reductions in 
under-5 mortality rate were driven by reductions in 
deaths among children aged 1–59 months, whereas most 
states had a much slower decline in neonatal mortality 
rate. The relative importance of preterm birth com-
plications increased over the 2000–15 period in states 
with large numbers of under-5 deaths. Diarrhoea had a 
faster decline than many other causes across almost all 
states. However, the decline was slower in states with 
high versus those with low under-5 mortality rates.
National efforts have been made to improve child 
survival in 2000–15 in India. The National Rural Health 
Mission was implemented in 2005 to increase maternal 
and child health services in rural areas, strategically 
focused in EAGA states and the northeast region, which 
might have contributed to the improvement in child 
survival and mitigated regional disparities.32–38 As a 
reference, the ratio of the highest regional under-5 
mortality rate (in the northeast region) to the lowest (in the 
south region) in India was 2 in 2015, compared with more 
than 4 in the highest and lowest in China.39 As the universal 
health coverage agenda is further advanced in India, child 
survival equity can hopefully be better addressed.33
Progress in India is crucial to improving child survival 
globally. The leading causes of preterm birth complications, 
pneumonia, intrapartum-related events, neonatal sepsis or 
meningitis, diarrhoea, and injuries should receive more 
attention from child survival policy makers and 
programmes. In this study, we considered the effect of the 
Hib vaccine on pneumonia and meningitis mortality. The 
newly introduced pneumococcal conjugate vaccine40 and 
second-dose measles vaccine41 are expected to further 
reduce mortality due to pneumonia and measles. Efforts 
to  increase vaccination coverage, including Mission 
Indradhanush10,42 and a measles–rubella vaccination 
campaign, launched by the government of India in 2017, 
might help to further reduce the number of deaths due to 
infectious causes.
Preterm birth complications were the leading cause of 
under-5 deaths in India in 2000–15, and the rate of 
mortality from this cause saw little change during 
this period, especially in EAGA states. Cost-effective 
interventions, such as kangaroo care, thermal control, 
breastfeeding support, and basic care for infections43 and 
breathing difficulties, could be considered.44–46 Efforts in 
integrated newborn care packages, such as integrated 
management of neonatal and childhood illnesses,36,47 could 
further improve neonatal health outcomes. However, 
evaluation of health initiatives shows varying programme 
governance and accountability across states. Therefore, 
high and consistent commitment from local government 
is crucial to ensure that programmes work as intended.35,48
Diarrhoea remains an important cause of death, 
particularly in states with high under-5 mortality rates 
and low socioeconomic status. However, improvement 
of diarrhoea survival has never been more promising.49 
Access to diarrhoea treatments, such as oral rehydration 
solution and zinc supplements, has significantly 
increased in the past decade3,4 through the engagement 
of accredited social health activist workers in community-
based health service provision.50–52 Nationwide campaigns, 
such as the Intensified Diarrhoea Control Fortnight, was 
launched in 2014 to create mass awareness of diarrhoea 
treatments.53 With the scale-up of these interventions, 
diarrhoea survival could be further improved in Indian 
states with high mortality.
The differences in numbers of cause-specific deaths 
between our study (MCEE), MDS, and GBD were largely 
due to 17% fewer all-cause under-5 deaths and 8% fewer 
livebirths estimated by the UN Inter-agency Group for 
Child Mortality Estimation than were estimated by GBD 
(appendix p 28).1,19,29 MCEE and GBD estimates for 
prematurity were not directly comparable to those from 
the MDS. The two physicians who reviewed each MDS 
record were not asked to distinguish between deaths due 
Figure 3: Distribution of causes of death by under-5 mortality rate stratum in 2015
35 states were grouped into five mortality strata on the basis of under-5 mortality rate in 2015: very low 
(≤25 deaths per 1000 livebirths; 12 states, 0·082 million under-5 deaths); low (>25–45 deaths per 1000 livebirths; 
12 states, 0·250 million deaths); medium (>45–55 deaths per 1000 livebirths; six states, 0·314 million under-5 
deaths); high (>55–65 deaths per 1000 livebirths; three states, 0·380 million under-5 deaths); and very high 
(>65 deaths per 1000 livebirths; two states, 0·175 million under-5 deaths). See appendix (p 15) for groupings.
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to disorders related to slow fetal growth and fetal 
malnutrition (P05) and those due to disorders related to 
short gestation and low birthweight (P07). More careful 
examination of the MDS data revealed that 56% of 
neonatal deaths coded as prematurity or low birthweight 
were reported as full-term low birthweight. MDS is 
investigating the feasibility of requiring physicians to 
distinguish between P05 and P07 in the future. For deaths 
at 1–59 months, where differences in cause-of-death 
classification were minor, MCEE estimated slightly more 
deaths due to pneumonia and diarrhoea and fewer due to 
injury and malaria (appendix p 30) than were estimated 
by MDS and GBD. State-level trends in all-cause mortality 
rates, mortality rates for neonatal infections, birth 
asphyxia or trauma, pneumonia, and diarrhoea were 
similar between MDS and MCEE, with the exception of 
some smaller and new states with less information 
reported (eg, Assam, Jharkhand, and Chhattisgarh; 
appendix pp 31–37).
Each of the approaches used to estimate state-level 
mortality rates in this study and in MDS had strengths 
and limitations. MCEE estimates were based on 
standardised procedures, making the estimates 
internationally comparable, but they might be less 
capable of reflecting short-term changes. By contrast, 
MDS estimates were based on annual data, which show 
more fluctuations for smaller causes (data not shown). 
Such fluctuations could reflect both real changes and 
data quality issues. Although representative and timely 
data from a high-quality vital registration system would 
be the ideal source of data, we believe in the value of both 
estimation approaches, which serve different audiences 
and purposes. We intended to compare our approach 
with the GBD state-level estimates, but were unable to do 
so because GBD estimates are only available through the 
visualisation tool, but are not yet downloadable. Improved 
transparency would promote understanding, comparison, 
and enhancement of global health estimates.30
The present study had some limitations. First, many 
states in the northeast region are small states with little 
data available from the sample registration system. To fill 
these data gaps, for example on neonatal mortality rate, 
we chose to borrow information from nearby states (in 
this case, Assam and West Bengal). In Assam, the 
proportion of under-5 deaths that were neonatal was 
37·3%. States in the northeast for which information was 
borrowed from Assam had a large share of the regional 
under-5 deaths, and the relatively low proportion of 
neonatal deaths in Assam might have led to an artificially 
low proportion of neonatal deaths in the entire northeast 
region. This borrowing of data would also affect 
cause-specific estimates because cause-specific mortality 
fractions were applied to all-cause deaths among 
neonates and older children separately. Consequently, 
although preterm birth com plications were the leading 
cause among neonates, they were not the leading cause 
among all children under 5 years of age in the northeast 
region. This limitation might also explain why, despite a 
high under-5 mortality rate, preterm birth complications 
were not the leading cause in the northeast region but 
were in the other regions.
A second limitation was that, although the modelling 
strategies used for neonates and older children were 
similar, the two age groups relied on different input data: 
neonatal data were taken from verbal autopsy studies 
from all high-mortality countries, whereas data for older 
children relied on Indian subnational verbal autopsy 
studies. Such a difference was justified because data 
availability varies by age group. The number of studies 
reporting Indian subnational causes of death among 
neonates was too small to derive stable estimates. 
Additionally, many of the India subnational studies had 
missing data for important causes such as pneumonia, 
thereby further reducing the reliability of estimates based 
only on Indian studies. When comparing the input data 
from India versus other high-mortality countries, we 
found no substantial differences in the cause-of-death 
distributions among neonates (appendix p 7). Thus, we 
Figure 4: Relative acceleration required by each state to meet Sustainable Development Goal targets on 
under-5 and neonatal mortality by 2030
Data are the required annual rate of reduction (in 2015–30) divided by the annual rate of reduction achieved in 
2000–15. States with a required relative increase of less than 1·0 are on track to meet the target by 2030. States with 
missing values have already met the target. States are ordered by number of under-5 deaths in 2015, with the highest 
at the top and lowest at the bottom. *Arunachal Pradesh, Manipur, Mizoram, Nagaland, Sikkim, and Tripura. 
†Andaman and Nicobar Islands, Chandigarh, Dadra and Nagar Haveli, Daman and Diu, Lakshadweep, and Puducherry.
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chose to use all high-mortality studies as inputs for the 
neonatal modelling.
Finally, our uncertainty calculations did not consider 
all sources of errors. For example, although we adopted 
the exponential growth assumption when interpolating 
for annual population estimates, the likely errors (albeit 
small) were not explicitly propagated in our uncertainty 
estimates. Similarly, borrowing estimates (eg, neonatal 
mortality rate) from another state might have incurred 
errors, and such errors were also not explicitly accounted 
for in our uncertainty estimation. To do so, we would 
have had to make assumptions about the distribution of 
such errors, which itself cannot be empirically tested.
In summary, our estimates are based on the most 
comprehensive set of high-quality, subnational, verbal 
autopsy studies to date. This study provides reliable, albeit 
conservative, time trends on all-cause and cause-specific 
under-5 mortality at the national and subnational levels in 
India with transparency. Future work is needed to further 
increase the resolution of estimates on all-cause estimates 
and particularly cause-specific estimates (eg, at district 
level). The demand for this information is driven by 
decentralised decision making and child survival 
programme efforts, such as the scaling-up of pneumococcal 
conjugate vaccine and the continuation of Mission 
Indradhanush at district level. Among older children, as 
vaccine coverage data were used as model inputs and in 
post-hoc adjustment, these estimates should not be used 
to infer causality between vaccine and mortality decline.
The evidence base for child mortality and causes of 
death can be improved through a combination of more 
and better data collection. Standard verbal autopsy 
instruments and cause-ascertaining methods should be 
implemented. Innovative data collection, such as 
minimally invasive tissue sampling54 or Countrywide 
Mortality Surveillance for Action,55 could be considered 
for better measurement of cause of death and potentially 
for more efficient and sustainable data acquisition. 
Advanced modelling approaches are essential to derive 
more reliable estimates. The direct and indirect effects of 
existing and newly scaled-up vaccines on infectious 
diseases should be routinely considered. National and 
subnational civil registration and vital statistics systems 
can be strengthened through in-country capacity building 
so that data on cause-specific mortality are routinely 
collected, promptly published, and publicly released 
using standard, transparent, and reproducible methods.5 
At the subnational level, building data capacity within 
local health systems, combined with collection of better 
and more timely data, and advances in estimation 
techniques for small areas,56 could lead to more precise 
estimates of child mortality and causes of death, which 
will, in turn, inform more effective child survival policy 
planning and programme evaluation in the SDG era.
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